Nephros, Inc. NEPH
NASDAQ
| 09/30/2026 | 06/30/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -6.56% | 15.45% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -6.56% | 15.45% | |||
| Cost of Revenue | 17.33% | -10.27% | |||
| Gross Profit | -18.38% | 34.51% | |||
| SG&A Expenses | 0.29% | -4.09% | |||
| Depreciation & Amortization | 0.00% | 0.00% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 6.60% | -6.08% | |||
| Operating Income | -58.70% | 1,150.52% | |||
| Income Before Tax | -57.69% | 764.29% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -57.23% | 755.00% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -57.23% | 755.00% | |||
| EBIT | -58.70% | 1,150.52% | |||
| EBITDA | -57.36% | 902.42% | |||
| EPS Basic | -57.30% | 741.98% | |||
| Normalized Basic EPS | -57.68% | 750.00% | |||
| EPS Diluted | -57.18% | 1,000.00% | |||
| Normalized Diluted EPS | -58.00% | 751.25% | |||
| Average Basic Shares Outstanding | 0.06% | 1.93% | |||
| Average Diluted Shares Outstanding | 0.82% | 1.11% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||